-
Je něco špatně v tomto záznamu ?
Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases
K. Syslova, P. Kačer, M. Kuzma, V. Najmanová, Z. Fenclová, S. Vlčková, J. Lebedová, D. Pelclová
Jazyk angličtina Země Nizozemsko
Typ dokumentu hodnotící studie, práce podpořená grantem
Grantová podpora
NR9338
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
- MeSH
- aldehydy analýza krev moč MeSH
- azbest toxicita MeSH
- biologické markery analýza krev moč MeSH
- dinoprost analogy a deriváty analýza krev moč MeSH
- extrakce na pevné fázi metody MeSH
- lidé středního věku MeSH
- lidé MeSH
- malondialdehyd analýza krev moč MeSH
- oxid křemičitý toxicita MeSH
- oxidační stres MeSH
- plicní nemoci etiologie krev metabolismus moč MeSH
- senioři MeSH
- studie případů a kontrol MeSH
- tandemová hmotnostní spektrometrie metody MeSH
- tělesné tekutiny chemie metabolismus MeSH
- vysokoúčinná kapalinová chromatografie metody MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- Publikační typ
- hodnotící studie MeSH
- práce podpořená grantem MeSH
Sensitive assay method was developed for a parallel, rapid and precise determination of the most prominent oxidative stress biomarkers: 8-iso-prostaglandin F(2alpha), malondialdehyde and 4-hydroxynonenal. The method consisted of a pre-treatment part a solid-phase extraction, for rapid and effective isolation of biomarkers from body fluids (exhaled breath condensate, plasma and urine) and the detection method LC-ESI-MS/MS, where the selected reaction monitoring mode was used for its extremely high degree of selectivity and the stable-isotope-dilution assay for its high precision of quantification. The developed method was characterized by the following parameters: the imprecision was below 14.3%, the mean inaccuracy was determined to be lower than 13.1%. The method was tested on samples obtained from patients diagnosed with asbestosis, pleural hyalinosis or silicosis, i.e. occupational lung diseases caused by fibrogenic dusts, inducing oxidative stress in the respiratory system, and then compared to samples from healthy subjects. The difference in concentration levels of biomarkers between the two groups was perceptible in all the body fluids (the difference observed in an exhaled breath condensate was statistically most significant).
- 000
- 03786naa 2200637 a 4500
- 001
- bmc11016722
- 003
- CZ-PrNML
- 005
- 20130329083801.0
- 008
- 110628s2009 ne e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Syslová, Kamila $7 xx0145898
- 245 10
- $a Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases / $c K. Syslova, P. Kačer, M. Kuzma, V. Najmanová, Z. Fenclová, S. Vlčková, J. Lebedová, D. Pelclová
- 314 __
- $a Institute of Chemical Technology, Technicka 5, 166 28 Prague 6, Czech Republic.
- 520 9_
- $a Sensitive assay method was developed for a parallel, rapid and precise determination of the most prominent oxidative stress biomarkers: 8-iso-prostaglandin F(2alpha), malondialdehyde and 4-hydroxynonenal. The method consisted of a pre-treatment part a solid-phase extraction, for rapid and effective isolation of biomarkers from body fluids (exhaled breath condensate, plasma and urine) and the detection method LC-ESI-MS/MS, where the selected reaction monitoring mode was used for its extremely high degree of selectivity and the stable-isotope-dilution assay for its high precision of quantification. The developed method was characterized by the following parameters: the imprecision was below 14.3%, the mean inaccuracy was determined to be lower than 13.1%. The method was tested on samples obtained from patients diagnosed with asbestosis, pleural hyalinosis or silicosis, i.e. occupational lung diseases caused by fibrogenic dusts, inducing oxidative stress in the respiratory system, and then compared to samples from healthy subjects. The difference in concentration levels of biomarkers between the two groups was perceptible in all the body fluids (the difference observed in an exhaled breath condensate was statistically most significant).
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a aldehydy $x analýza $x krev $x moč $7 D000447
- 650 _2
- $a azbest $x toxicita $7 D001194
- 650 _2
- $a biologické markery $x analýza $x krev $x moč $7 D015415
- 650 _2
- $a tělesné tekutiny $x chemie $x metabolismus $7 D001826
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
- 650 _2
- $a dinoprost $x analogy a deriváty $x analýza $x krev $x moč $7 D015237
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a plicní nemoci $x etiologie $x krev $7 D008171
- 650 _2
- $a plicní nemoci $x metabolismus $x moč $7 D008171
- 650 _2
- $a malondialdehyd $x analýza $x krev $x moč $7 D008315
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a oxid křemičitý $x toxicita $7 D012822
- 650 _2
- $a extrakce na pevné fázi $x metody $7 D052616
- 650 _2
- $a tandemová hmotnostní spektrometrie $x metody $7 D053719
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kačer, Petr, $d 1969- $7 xx0081992
- 700 1_
- $a Kuzma, Marek, $d 1974- $7 xx0075964
- 700 1_
- $a Najmanová, Věra. $7 _AN063344
- 700 1_
- $a Fenclová, Zdeňka $7 xx0074215
- 700 1_
- $a Vlčková, Štěpánka $7 xx0162780
- 700 1_
- $a Lebedová, Jindřiška $7 xx0062564
- 700 1_
- $a Pelclová, Daniela, $d 1953- $7 nlk20010096163
- 773 0_
- $t Journal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences $w MED00006642 $g Roč. 877, č. 24 (2009), s. 2477-2486
- 910 __
- $a ABA008 $b x $y 2
- 990 __
- $a 20110715144220 $b ABA008
- 991 __
- $a 20130329084025 $b ABA008
- 999 __
- $a ok $b bmc $g 864047 $s 726513
- BAS __
- $a 3
- BMC __
- $a 2009 $x MED00006642 $b 877 $c 24 $d 2477-2486 $m Journal of chromatography. B, Analytical technologies in the biomedical and life sciences $n J Chromatogr B Analyt Technol Biomed Life Sci
- GRA __
- $a NR9338 $p MZ0
- LZP __
- $a 2011-3B09/BBjvme